Sandesh Mahatme - Director at Spyre Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Director
Stock Symbol
SYRE on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Sandesh Mahatme since 9/17/2023

Holdings reported by Sandesh Mahatme for Spyre Therapeutics, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Director Stock Option (right to buy) 43K Jun 7, 2022 Direct Common Stock

Transactions reported by Sandesh Mahatme for Spyre Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.